{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:35:18Z","timestamp":1792636518093,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.neulet.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:31:09Z","timestamp":1549884669000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["\u03b3-Secretase and its modulators: Twenty years and beyond"],"prefix":"10.1016","volume":"701","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-3295","authenticated-orcid":false,"given":"Weiming","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.02.011_bib0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-140-8-200404200-00047","article-title":"Alzheimer disease: mechanistic understanding predicts novel therapies","volume":"140","author":"Selkoe","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","article-title":"Amyloid b-peptide is produced by cultured cells during normal metabolism","volume":"359","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","article-title":"Production of the Alzheimer amyloid b protein by normal proteolytic processing","volume":"258","author":"Shoji","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/pr050475v","article-title":"Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry","volume":"5","author":"Portelius","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neulet.2019.02.011_bib0035","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/j.1471-4159.1993.tb09841.x","article-title":"Characterization of b-amyloid peptide from human cerebrospinal fluid","volume":"61","author":"Vigo-Pelfrey","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0040","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.neulet.2019.02.011_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neulet.2019.02.011_bib0055","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1523\/JNEUROSCI.5384-05.2006","article-title":"Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology","volume":"26","author":"Deng","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"Abeta40 inhibits amyloid deposition in vivo","volume":"27","author":"Kim","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0065","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.1021\/bi00032a022","article-title":"Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells","volume":"34","author":"Asami-Odaka","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.neulet.2019.02.011_bib0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.1993.tb23043.x","article-title":"The C-terminus of the beta protein is critical in amyloidogenesis","volume":"695","author":"Jarrett","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0075","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1021\/ja8092604","article-title":"Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization","volume":"131","author":"Murray","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neulet.2019.02.011_bib0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jmb.2007.04.014","article-title":"Abeta40 protects non-toxic Abeta42 monomer from aggregation","volume":"369","author":"Yan","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0085","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.1074\/jbc.M803159200","article-title":"The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity","volume":"283","author":"Jan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0090","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1073\/pnas.0400895101","article-title":"Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer\u2019s disease","volume":"101","author":"Iijima","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.02.011_bib0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","article-title":"Abeta42 is essential for parenchymal and vascular amyloid deposition in mice","volume":"47","author":"McGowan","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.embor.7400896","article-title":"When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42\/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease","volume":"8","author":"Wolfe","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neulet.2019.02.011_bib0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.embor.7400897","article-title":"Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease","volume":"8","author":"De Strooper","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neulet.2019.02.011_bib0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2019-splice-site mutations in tau with the inherited FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0115","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0125","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7","article-title":"Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants","volume":"62","author":"Flaherty","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2019.02.011_bib0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","article-title":"Phosphorylation sites on Tau identified by nanoelectrospray mass spectrometry","volume":"74","author":"Reynolds","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jamaneurol.2014.2482","article-title":"Effect of potent gamma-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers","volume":"71","author":"Liu","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025788","article-title":"Anti-abeta drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer\u2019s disease","volume":"6","author":"Yahata","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.02.011_bib0155","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/anie.200802621","article-title":"Development of tau aggregation inhibitors for Alzheimer\u2019s disease","volume":"48","author":"Bulic","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neulet.2019.02.011_bib0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmac."},{"key":"10.1016\/j.neulet.2019.02.011_bib0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and g-secretase activity","volume":"398","author":"Wolfe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","article-title":"Aph-1 and pen-2 are required for Notch pathway signaling, g-secretase cleavage of bAPP and presenilin protein accumulation","volume":"3","author":"Francis","year":"2002","journal-title":"Dev. Cell."},{"key":"10.1016\/j.neulet.2019.02.011_bib0180","doi-asserted-by":"crossref","first-page":"20117","DOI":"10.1074\/jbc.M213107200","article-title":"Membrane topology of gamma-secretase component PEN-2","volume":"278","author":"Crystal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0969-9961(03)00123-2","article-title":"Functional gamma-secretase complex assembly in Golgi\/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates","volume":"14","author":"Baulac","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","article-title":"Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex","volume":"38","author":"De Strooper","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1083\/jcb.200304014","article-title":"Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex","volume":"161","author":"Hu","year":"2003","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0200","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1037392100","article-title":"Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2","volume":"100","author":"Kimberly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.02.011_bib0205","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1074\/jbc.C200648200","article-title":"PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1","volume":"278","author":"Luo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the gamma-secretase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncb960","article-title":"Reconstitution of gamma-secretase activity","volume":"5","author":"Edbauer","year":"2003","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0220","doi-asserted-by":"crossref","first-page":"21435","DOI":"10.1073\/pnas.1013246107","article-title":"Activation and intrinsic gamma-secretase activity of presenilin 1","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.02.011_bib0225","doi-asserted-by":"crossref","first-page":"21236","DOI":"10.1073\/pnas.1016284108","article-title":"And four equals one: presenilin takes the gamma-secretase role by itself","volume":"107","author":"Lessard","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.02.011_bib0230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/35015085","article-title":"Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1","volume":"405","author":"Li","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0235","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.wnf.0000167360.27670.29","article-title":"Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers","volume":"28","author":"Siemers","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0240","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archneur.65.8.1031","article-title":"Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease","volume":"65","author":"Fleisher","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0250","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.4161\/cbt.8.21.9921","article-title":"Emerging role of Notch signaling in epidermal differentiation and skin cancer","volume":"8","author":"Panelos","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0255","doi-asserted-by":"crossref","first-page":"20228","DOI":"10.1073\/pnas.0910757106","article-title":"Modulation of gamma-secretase specificity using small molecule allosteric inhibitors","volume":"106","author":"Shelton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2019.02.011_bib0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bmcl.2008.11.116","article-title":"(S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor","volume":"19","author":"Cole","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0270","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/jpet.109.152975","article-title":"Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer\u2019s disease","volume":"331","author":"Martone","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0275","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1021\/jm801252w","article-title":"Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer\u2019s disease","volume":"51","author":"Mayer","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ml1000239","article-title":"Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable g-secretase inhibitor","volume":"1","author":"Gillman","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0285","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1021\/bi301137h","article-title":"BMS-708,163 targets presenilin and lacks Notch-sparing activity","volume":"51","author":"Crump","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.neulet.2019.02.011_bib0290","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.clinthera.2012.01.022","article-title":"Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral gamma-secretase inhibitor BMS-708163 (avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers","volume":"34","author":"Tong","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0295","first-page":"1","article-title":"Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease","volume":"13","author":"Coric","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0300","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0305","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1093\/emboj\/cdf541","article-title":"Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1","volume":"21","author":"Okochi","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2019.02.011_bib0310","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrm910","article-title":"Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling","volume":"3","author":"Fortini","year":"2002","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0896-6273(02)00585-8","article-title":"Aph-2\/Nicastrin: an essential component of gamma-secretase and regulator of Notch signaling and Presenilin localization","volume":"33","author":"Kopan","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0320","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1242\/jcs.00651","article-title":"Intramembrane proteolysis by presenilin and presenilin-like proteases","volume":"116","author":"Xia","year":"2003","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2011-101065","article-title":"The many substrates of presenilin\/gamma-secretase","volume":"25","author":"Haapasalo","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0330","doi-asserted-by":"crossref","first-page":"46107","DOI":"10.1074\/jbc.M307757200","article-title":"Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor","volume":"278","author":"Searfoss","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0335","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0340","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1471-4159.2006.03648.x","article-title":"Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss","volume":"96","author":"Campbell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0345","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1074\/jbc.M512521200","article-title":"The cytosolic loop of the gamma -secretase component presenilin enhancer 2 (Pen-2) protects zebrafish embryos from apoptosis","volume":"281","author":"Zetterberg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0350","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/embo-reports\/kvf124","article-title":"A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish","volume":"3","author":"Geling","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neulet.2019.02.011_bib0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-6606-1-15","article-title":"Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein","volume":"1","author":"Yang","year":"2008","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neulet.2019.02.011_bib0360","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1471-4159.2010.06681.x","article-title":"In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer\u2019s amyloid reducing gamma-secretase inhibitors","volume":"113","author":"Yang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1472-6750-10-24","article-title":"Phenotypic analysis of images of zebrafish treated with Alzheimer\u2019s gamma-secretase inhibitors","volume":"10","author":"Arslanova","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0370","doi-asserted-by":"crossref","first-page":"22350","DOI":"10.1074\/jbc.M110.116962","article-title":"A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity","volume":"285","author":"Heilig","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0375","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0896-6273(01)00417-2","article-title":"APP processing and synaptic plasticity in presenilin-1 conditional knockout mice","volume":"31","author":"Yu","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","article-title":"Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration","volume":"42","author":"Saura","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0385","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1523\/JNEUROSCI.1320-09.2009","article-title":"Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration","volume":"29","author":"Tabuchi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0390","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144758","article-title":"Gamma-secretase modulators and APH1 isoforms modulate gamma-secretase cleavage but not position of epsilon-cleavage of the amyloid precursor protein (APP)","volume":"10","author":"Lessard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.02.011_bib0400","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1038\/emboj.2011.372","article-title":"Phenylpiperidine-type gamma-secretase modulators target the transmembrane domain 1 of presenilin 1","volume":"30","author":"Ohki","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2019.02.011_bib0405","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cn200098p","article-title":"Piperidine acetic acid based gamma-secretase modulators directly bind to presenilin-1","volume":"2","author":"Crump","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0410","doi-asserted-by":"crossref","first-page":"37181","DOI":"10.1074\/jbc.C111.276972","article-title":"Novel gamma-secretase enzyme modulators directly target presenilin protein","volume":"286","author":"Ebke","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0415","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature07055","article-title":"Substrate-targeting gamma-secretase modulators","volume":"453","author":"Kukar","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0420","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0197-4580(01)00311-6","article-title":"Modeling microglial activation in Alzheimer\u2019s disease with human postmortem microglial cultures","volume":"22","author":"Lue","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.02.011_bib0425","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice","volume":"173","author":"Janelsins","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0430","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0435","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0440","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0445","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0450","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.02.011_bib0455","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0460","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0465","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2019.02.011_bib0470","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/jm101168r","article-title":"g-Secretase modulators as potential disease modifying anti-Alzheimer\u2019s drugs","volume":"54","author":"Oehlrich","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0475","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/emboj.2011.410","article-title":"Target of gamma-secretase modulators, presenilin marks the spot","volume":"30","author":"Crump","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2019.02.011_bib0480","doi-asserted-by":"crossref","first-page":"30748","DOI":"10.1074\/jbc.M304824200","article-title":"Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain","volume":"278","author":"Weggen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0485","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1471-4159.2004.02154.x","article-title":"Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures","volume":"88","author":"Gasparini","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0490","doi-asserted-by":"crossref","first-page":"50970","DOI":"10.1074\/jbc.M307699200","article-title":"Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity","volume":"278","author":"Qin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0495","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease","volume":"23","author":"Yan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.02.011_bib0500","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower abeta 42 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.02.011_bib0505","doi-asserted-by":"crossref","first-page":"31831","DOI":"10.1074\/jbc.M303592200","article-title":"Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity","volume":"278","author":"Weggen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0510","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1090154","article-title":"Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho","volume":"302","author":"Zhou","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0515","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.phrs.2006.12.010","article-title":"In vitro and in vivo profiling of CHF5022 and CHF5074 two beta-amyloid1-42 lowering agents","volume":"55","author":"Imbimbo","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neulet.2019.02.011_bib0520","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2008.00097.x","article-title":"CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer\u2019s disease","volume":"156","author":"Imbimbo","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-2010-1366","article-title":"CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer\u2019s disease","volume":"20","author":"Imbimbo","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0530","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/13892037113149990144","article-title":"CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: A 12-week, double-blind, placebo- controlled study","volume":"10","author":"Ross","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neulet.2019.02.011_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2013.04.271","article-title":"Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074","author":"Ross","year":"2013","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neulet.2019.02.011_bib0540","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","article-title":"TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice","volume":"26","author":"Zhao","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0545","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.02.011_bib0550","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.107.129007","article-title":"1-(3\u2019,4\u2019-Dichloro-2-fluoro[1,1\u2019-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease without causing peripheral toxicity","volume":"323","author":"Imbimbo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13195-015-0137-y","article-title":"Modulation of Abeta42 in vivo by gamma-secretase modulator in primates and humans","volume":"7","author":"Ling","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0560","article-title":"E2012: A novel Gamma-secretase modulator; Pharmacology part","author":"Hashimoto","year":"2010","journal-title":"International Conference on Alzheimer\u2019s Disease 2010"},{"key":"10.1016\/j.neulet.2019.02.011_bib0565","article-title":"E2012: A novel Gamma-secretase modulator; Mechanism of action","author":"Amino","year":"2010","journal-title":"International Conference on Alzheimer\u2019s Disease 2010"},{"key":"10.1016\/j.neulet.2019.02.011_bib0570","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuron.2010.08.018","article-title":"Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer\u2019s disease","volume":"67","author":"Kounnas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0575","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bmcl.2010.11.111","article-title":"Quinazolinones as gamma-secretase modulators","volume":"21","author":"Fischer","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0580","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1016\/j.bmcl.2011.04.089","article-title":"Triazoles as gamma-secretase modulators","volume":"21","author":"Fischer","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0585","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bmcl.2010.02.008","article-title":"Purine derivatives as potent gamma-secretase modulators","volume":"20","author":"Rivkin","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0590","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/ern.09.24","article-title":"Secretase inhibitors and modulators for Alzheimer\u2019s disease treatment","volume":"9","author":"Tomita","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neulet.2019.02.011_bib0595","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bmcl.2009.11.101","article-title":"Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators","volume":"20","author":"Rivkin","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0600","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bmcl.2009.11.034","article-title":"Fluorinated piperidine acetic acids as gamma-secretase modulators","volume":"20","author":"Stanton","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0605","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bmcl.2009.08.072","article-title":"Piperidine-derived gamma-secretase modulators","volume":"20","author":"Hall","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2019.02.011_bib0610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000313903","article-title":"TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to gamma-secretase modulation and amyloid-beta lowering by GSM-10h","volume":"8","author":"Hussain","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0615","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000324511","article-title":"Dynamics of Abeta42 reduction in plasma, CSF and brain of rats treated with the gamma-secretase modulator, GSM-10h","volume":"8","author":"Hawkins","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neulet.2019.02.011_bib0620","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.M708754200","article-title":"Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation","volume":"283","author":"Page","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.02.011_bib0625","article-title":"Gamma secretase modulators that acutely reduce soluble A\u03b2 42 levels in Non-transgenic rodents","author":"Chesworth","year":"2010","journal-title":"239th National Meeting of the American Chemical Society"},{"key":"10.1016\/j.neulet.2019.02.011_bib0630","article-title":"Pharmacokinetic and pharmacodynamic analysis of the gamma-secretase modulator (GSM) EVP-0015962","author":"Felsenstein","year":"2010","journal-title":"International Conference on Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neulet.2019.02.011_bib0635","article-title":"The gamma secretase modulator EVP-0015962 improves cognitive deficits in Tg2576 mice concomitant with decreases in A\u03b242","author":"Rogers","year":"2010","journal-title":"International Conference on Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neulet.2019.02.011_bib0640","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.2011.01207.x","article-title":"Chronic treatment with a novel gamma-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer\u2019s disease","volume":"163","author":"Van Broeck","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2019.02.011_bib0645","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40262-012-0005-x","article-title":"Multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects","volume":"51","author":"Dockens","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neulet.2019.02.011_bib0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.116.232249","article-title":"Robust translation of gamma-secretase modulator pharmacology across preclinical species and human subjects","volume":"358","author":"Toyn","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0655","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.116.232256","article-title":"The gamma-secretase modulator, BMS-932481, modulates Abeta peptides in the plasma and cerebrospinal fluid of healthy volunteers","volume":"358","author":"Soares","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0660","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and toxicological properties of the potent oral gamma-secretase modulator BPN-15606","volume":"362","author":"Wagner","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0665","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0670","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","article-title":"Anti-abeta therapeutics in Alzheimer\u2019s disease: the need for a paradigm shift","volume":"69","author":"Golde","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.02.011_bib0675","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-016-0199-5","article-title":"Characterization of FRM-36143 as a new gamma-secretase modulator for the potential treatment of familial Alzheimer\u2019s disease","volume":"8","author":"Blain","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neulet.2019.02.011_bib0680","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.02.011_bib0685","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-015-0021-z","article-title":"Cholestenoic acid, an endogenous cholesterol metabolite, is a potent gamma-secretase modulator","volume":"10","author":"Jung","year":"2015","journal-title":"Mol. Neurodegener."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019300941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019300941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:25:33Z","timestamp":1759609533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019300941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":137,"alternative-id":["S0304394019300941"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.02.011","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b3-Secretase and its modulators: Twenty years and beyond","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}